BioPerfectus Competitors and Similar CompaniesClear all

BioPerfectus's competitors and similar companies include Fort Wayne Metals, Sterigenics, Promed and Shanghai Rightongene Biotechnology.

	BioPerfectus BioPerfectus (also known as Jiangsu Bioperfectus Technologies, 江苏硕世生物科技股份有限公司) is a company focused on nucleic acid extraction systems, PCR-based assays, and related consumables.	Fort Wayne Metals Fort Wayne Metals is a manufacturer of precision wire-based devices for medical industries.	Sterigenics Sterigenics is a medical device company.	Promed Promed is a manufacturer and distributor of medical and laboratory devices.	Shanghai Rightongene Biotechnology Shanghai Rightongene Biotechnology (上海睿昂基因科技股份有限公司) is a company that manufactures and sells diagnostic products.
Founding Date	Founding Date 2010	Founding Date 1971	Founding Date 1978	Founding Date 1968	Founding Date 2012
Type	Type Public	Type Private	Type Private	Type Private	Type Public
Tags	Tags Healthcare biotech medical devices	Tags Healthcare biotech medical devices	Tags Healthcare biotech medical devices	Tags Healthcare biotech medical devices	Tags Healthcare biotech medical devices
Locations	Locations Taizhou, CN HQ Shanghai, CN Belfast, GB Natick, US	Locations Fort Wayne, US HQ Castlebar, IE Minato City, JP	Locations Broadview Heights, US HQ Oak Brook, US	Locations Panamá, PA HQ San Pedro, CR Santo Domingo, DO San Salvador, SV Ciudad De Guatemala, GT Managua, NI	Locations CN HQ
Employees	Employees 592	Employees 7481% increase	Employees 1,050	Employees 1,3231% increase	Employees 401
Valuation ($)	Valuation ($) 616.7 m	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) 132.9 m
Financial
Revenue (est.)	Revenue (est.) ¥324.6m (FY, 2024)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) ¥170.7m (FY, 2025)
Cost of goods	Cost of goods ¥132m (FY, 2024)	Cost of goods N/A	Cost of goods N/A	Cost of goods N/A	Cost of goods ¥43.6m (FY, 2025)
Gross profit	Gross profit ¥210.9m (FY, 2024)	Gross profit N/A	Gross profit N/A	Gross profit N/A	Gross profit ¥130.3m (FY, 2025)
Net income	Net income (¥2m) (FY, 2024)	Net income N/A	Net income N/A	Net income N/A	Net income (¥60.4m) (FY, 2025)